Cargando…
Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
Li–Fraumeni syndrome (LFS) is a hereditary tumor that exhibits autosomal dominant inheritance. LFS develops in individuals with a pathogenic germline variant of the cancer-suppressor gene, TP53 (individuals with TP53 pathogenic variant). The number of individuals with TP53 pathogenic variant among t...
Autores principales: | Kumamoto, Tadashi, Yamazaki, Fumito, Nakano, Yoshiko, Tamura, Chieko, Tashiro, Shimon, Hattori, Hiroyoshi, Nakagawara, Akira, Tsunematsu, Yukiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595164/ https://www.ncbi.nlm.nih.gov/pubmed/34633580 http://dx.doi.org/10.1007/s10147-021-02011-w |
Ejemplares similares
-
Correction to: Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
por: Kumamoto, Tadashi, et al.
Publicado: (2021) -
Characteristics of Li‐Fraumeni syndrome in Japan: A review study by the special committee of JSHT
por: Funato, Michinori, et al.
Publicado: (2021) -
Li-Fraumeni Syndrome
por: Vogel, Wendy H.
Publicado: (2017) -
Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes
por: Frebourg, Thierry, et al.
Publicado: (2020) -
Hematologic malignancies and Li–Fraumeni syndrome
por: Swaminathan, Mahesh, et al.
Publicado: (2019)